TBC1D9B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.276800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.914820E-01
Normal-vs-Stage2
3.032800E-01
Normal-vs-Stage3
5.042400E-02
Normal-vs-Stage4
5.707600E-01
Stage1-vs-Stage2
8.096400E-01
Stage1-vs-Stage3
6.471600E-02
Stage1-vs-Stage4
8.253400E-01
Stage2-vs-Stage3
9.232200E-02
Stage2-vs-Stage4
6.784200E-01
Stage3-vs-Stage4
1.715020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.195000E-01
Normal-vs-AfricanAmerican
5.939800E-02
Normal-vs-Asian
5.359600E-01
Caucasian-vs-AfricanAmerican
5.009200E-01
Caucasian-vs-Asian
8.608200E-01
AfricanAmerican-vs-Asian
5.817800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.421800E-01
Normal-vs-Female
3.244000E-01
Male-vs-Female
8.250200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.906620E-01
Normal-vs-Age(41-60Yrs)
7.240800E-01
Normal-vs-Age(61-80Yrs)
2.189200E-01
Normal-vs-Age(81-100Yrs)
2.089600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.277000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.654600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.596800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.181300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.930100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.080200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.513190E-01
Normal-vs-Daily Drinker
5.109000E-01
Normal-vs-Weekly Drinker
5.534400E-01
Normal-vs-Occasional Drinker
7.993600E-01
Normal-vs-Social Drinker
3.669200E-01
Non Drinker-vs-Daily Drinker
2.418200E-01
Non Drinker-vs-Weekly Drinker
1.936580E-01
Non Drinker-vs-Occasional Drinker
6.537600E-02
Non Drinker-vs-Social Drinker
1.859600E-01
Daily Drinker-vs-Weekly Drinker
8.522000E-01
Daily Drinker-vs-Occasional Drinker
5.009800E-01
Daily Drinker-vs-Social Drinker
9.328000E-01
Weekly Drinker-vs-Occasional Drinker
6.573400E-01
Weekly Drinker-vs-Social Drinker
9.008800E-01
Occasional Drinker-vs-Social Drinker
5.408000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.828800E-01
Normal-vs-Grade 2
6.500800E-01
Normal-vs-Grade 3
6.100000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.243200E-01
Grade 1-vs-Grade 3
9.493500E-02
Grade 1-vs-Grade 4
4.828800E-01
Grade 2-vs-Grade 3
2.875800E-01
Grade 2-vs-Grade 4
6.500800E-01
Grade 3-vs-Grade 4
6.100000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.703900E-02
Normal-vs-NonDiabetic
4.708200E-01
Diabetic-vs-NonDiabetic
3.029800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.492800E-01
Normal-vs-NoPancreatitis
3.230600E-01
Pancreatitis-vs-NoPancreatitis
2.026600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.004200E-01
Normal-vs-N1
2.958000E-01
N0-vs-N1
6.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.331000E-01
Normal-vs-TP53-NonMutant
4.186600E-01
TP53-Mutant-vs-TP53-NonMutant
7.649000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
